Growth Metrics

BridgeBio Pharma (BBIO) Cash from Operations (2018 - 2026)

BridgeBio Pharma recorded quarterly Cash from Operations of 197279000.0 in Q1 2026, down 249.66% quarter-over-quarter from 56420000.0 in Q4 2025, and up 0.98% year-over-year from 195361032.87 in Q1 2025.

BridgeBio Pharma's Cash from Operations history runs 9 years deep, the most recent figure standing at 197279000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 0.98% year-over-year to 197279000.0; the TTM figure through Mar 2026 stood at 443954000.0 (up 11.28% YoY), while the FY2025 annual figure was 445910000.0, up 14.37% from the prior year.
  • Cash from Operations came in at 197279000.0 for Q1 2026 at BridgeBio Pharma, down from 56420000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 74703000.0 in Q2 2024 to a low of 219537000.0 in Q1 2024.
  • A 5-year average of 124184058.82 and a median of 135163000.0 in 2022 frame the typical range for Cash from Operations.
  • Across the five-year window, Cash from Operations tumbled 272.22% in 2023 and surged 165.9% in 2024, its largest moves.
  • BridgeBio Pharma's Cash from Operations stood at 93243000.0 in 2022, then sank by 33.86% to 124819000.0 in 2023, then tumbled by 56.49% to 195326000.0 in 2024, then surged by 71.11% to 56420000.0 in 2025, then slumped by 249.66% to 197279000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 197279000.0, 56420000.0, and 109574000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -1.67 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.43 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 1.08 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 70.50 Mn
10 BridgeBio Pharma 12.91 Bn 11.98 Bn 184.58 Mn -197.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -197.28 Mn
Mar 31, 2026 -197.28 Mn
Dec 31, 2025 -56.42 Mn
Dec 31, 2025 -56.42 Mn
Sep 30, 2025 -109.57 Mn
Sep 30, 2025 -109.57 Mn
Jun 30, 2025 -80.68 Mn
Jun 30, 2025 -80.68 Mn
Mar 31, 2025 -199.24 Mn
Mar 31, 2025 -199.24 Mn
Dec 31, 2024 -195.33 Mn
Dec 31, 2024 -195.33 Mn
Sep 30, 2024 -180.57 Mn
Sep 30, 2024 -180.57 Mn
Jun 30, 2024 74.70 Mn
Jun 30, 2024 74.70 Mn
Mar 31, 2024 -219.54 Mn
Mar 31, 2024 -219.54 Mn
Dec 31, 2023 -124.82 Mn
Dec 31, 2023 -124.82 Mn
Sep 30, 2023 -145.23 Mn
Sep 30, 2023 -145.23 Mn
Jun 30, 2023 -113.35 Mn
Jun 30, 2023 -113.35 Mn
Mar 31, 2023 -144.32 Mn
Mar 31, 2023 -144.32 Mn
Dec 31, 2022 -93.24 Mn
Dec 31, 2022 -93.24 Mn
Sep 30, 2022 -135.16 Mn
Sep 30, 2022 -135.16 Mn
Jun 30, 2022 -30.45 Mn
Jun 30, 2022 -30.45 Mn
Mar 31, 2022 -160.64 Mn
Mar 31, 2022 -160.64 Mn
Dec 31, 2021 -133.90 Mn
Dec 31, 2021 -133.90 Mn
Sep 30, 2021 -121.56 Mn
Sep 30, 2021 -121.56 Mn
Jun 30, 2021 -91.71 Mn
Jun 30, 2021 -91.71 Mn
Mar 31, 2021 -150.77 Mn
Mar 31, 2021 -150.77 Mn
Dec 31, 2020 -96.26 Mn
Dec 31, 2020 -96.26 Mn
Sep 30, 2020 -131.68 Mn
Sep 30, 2020 -131.68 Mn
Jun 30, 2020 -87.85 Mn
Jun 30, 2020 -87.85 Mn
Mar 31, 2020 -83.92 Mn
Mar 31, 2020 -83.92 Mn
Dec 31, 2019 -76.20 Mn
Dec 31, 2019 -76.20 Mn
Sep 30, 2019 -50.00 Mn
Sep 30, 2019 -50.00 Mn
Jun 30, 2019 -68.25 Mn
Jun 30, 2019 -68.25 Mn
Mar 31, 2019 -59.14 Mn
Mar 31, 2019 -59.14 Mn
Dec 31, 2018 -46.41 Mn
Dec 31, 2018 -46.41 Mn
Sep 30, 2018 -38.32 Mn
Sep 30, 2018 -38.32 Mn